Published in Cell Immunol on April 01, 1979
Human serum induces maturation of human monocytes in vitro. Changes in cytolytic activity, intracellular lysosomal enzymes, and nonspecific esterase activity. Am J Pathol (1983) 1.65
In vitro tuberculin reactivity of lymphocytes from patients with tuberculous pleurisy. Infect Immun (1982) 1.00
Modulation of mitogen-induced proliferation of autologous peripheral blood lymphocytes by human alveolar macrophages. Infect Immun (1982) 0.98
Pokeweed-mitogen induced lymphocyte proliferation: the effect of stimulation on mononuclear phagocytic cells. Immunology (1980) 0.94
Gamma interferon production by combinations of human peripheral blood lymphocytes, monocytes, and cultured macrophages. Infect Immun (1982) 0.92
Regulation of human B cell activation by prostaglandin E2. Suppression of the generation of immunoglobulin-secreting cells. J Clin Invest (1985) 0.86
Bovine monocytes and macrophages: an accessory role in suppressor-cell generation by Con A and in lectin-induced proliferation. Immunology (1983) 0.86
In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of mononuclear phagocytes in lymphocyte proliferation. Immunology (1982) 0.83
The effect of human monocytes and macrophages on lymphocyte proliferation. Immunology (1982) 0.82
Isolation of human monocytes by rosetting with antibody coated human erythrocytes and isopycnic gradient centrifugation. Clin Exp Immunol (1982) 0.80
An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods (1974) 6.54
Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med (1982) 3.82
Effects of corticosteroid therapy on human monocyte function. N Engl J Med (1975) 1.96
Effects of corticosteroids on human monocyte function. J Clin Invest (1974) 1.81
Adriamycin cardiotoxicity in man. Ann Intern Med (1974) 1.66
Phase I study of repeated cycles of high-dose cyclophosphamide, etoposide, and cisplatin administered without bone marrow transplantation. J Clin Oncol (1990) 1.42
The mechanism of retrovirus suppression of human T cell proliferation in vitro. J Immunol (1983) 1.39
GM-CSF, carboplatin, doxorubicin: a phase I study. Cancer Chemother Pharmacol (1994) 1.38
Cryoglobulinemia in infectious mononucleosis: quantitation and characterization of the cryoproeins. J Lab Clin Med (1968) 1.23
Frequent association of IgMlambda with crystalline inclusions in chronic lymphatic leukemic lymphocytes. N Engl J Med (1973) 1.20
Antinuclear antibodies in infectious mononucleosis. Lancet (1968) 1.17
Immunochemical studies on blood groups. XXXIII. The effects. of alkaline borohydride and of alkali on blood group A, B, and H substances. Biochemistry (1965) 1.12
Studies on human antibodies. IV. Purification and properties of anti-A and anti-B obtained by absorption and elution from insoluble blood group substances. J Exp Med (1966) 1.09
Differentiation-associated alteration in human monocyte-macrophage accessory cell function. J Immunol (1983) 1.08
Recurrent chromosomal defects are found in most patients with non-Hodgkin's-lymphoma. Cancer Genet Cytogenet (1984) 1.06
Cell-cell interaction in erythropoiesis. Role of human monocytes. J Clin Invest (1978) 1.06
From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera. Semin Hematol (1997) 1.05
Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection. Arch Pathol Lab Med (2000) 1.05
Complement-dependent opsonization of incompatible erythrocytes by human secretory IgA. J Immunol (1972) 1.02
Hemoglobin Andrew-Minneapolis alpha 2 A beta 2 144 Lys leads to Asn: a new high-oxygen-affinity mutant human hemoglobin. Blood (1974) 1.00
Red-cell-membrane polypeptide aggregates in glucose-6-phosphate dehydrogenase mutants with chronic hemolytic disease. A clue to the mechanism of hemolysis. N Engl J Med (1979) 0.98
Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study. Cancer (1994) 0.97
The effect of gamma interferon on IL-1 secretion of in vitro differentiated human macrophages. J Leukoc Biol (1985) 0.97
Membrane polypeptide aggregates in glucose 6-phosphate dehydrogenase-deficient and in vitro aged red blood cells. J Lab Clin Med (1978) 0.97
Heterogeneity among human lymphocyte effector cells mediating spontaneous lymphocyte-mediated cytotoxicity. Int J Cancer (1978) 0.95
Maternal and paternal lineages of the Samaritan isolate: mutation rates and time to most recent common male ancestor. Ann Hum Genet (2003) 0.95
Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience. J Clin Oncol (1999) 0.94
The population of paroxysmal nocturnal hemoglobinuria neutrophils deficient in decay-accelerating factor is also deficient in alkaline phosphatase. Blood (1988) 0.94
In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection. Br J Haematol (1982) 0.94
Human monocyte-induced tumor cell cytotoxicity. Blood (1978) 0.93
Characterization and comparison of human monocyte- and macrophage-induced tumor cell cytotoxicity. J Lab Clin Med (1979) 0.93
Enhancement of Fc receptor function during human monocyte differentiation in vitro. J Reticuloendothel Soc (1981) 0.91
Corticosteroid alteration of human monocyte to macrophage differentiation. J Immunol (1982) 0.91
Phase II study of intravenous bolus recombinant interleukin-2 in advanced malignant melanoma: Southwest Oncology Group study. J Natl Cancer Inst (1991) 0.89
Interleukin 1 stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanism. Thromb Haemost (1986) 0.88
Differential expression of insulin-like growth factor binding proteins in high versus low Gleason score prostate cancer. J Urol (1998) 0.87
Lysozyme stimulates lymphocyte proliferation in monocyte-depleted mixed lymphocyte cultures. J Lab Clin Med (1982) 0.87
Leukocytosis and large cell lung cancer. A frequent association. Cancer (1987) 0.87
Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in the treatment of refractory chronic lymphocytic leukemia. Cancer Treat Rep (1979) 0.85
Immune mechanisms for destruction of erythrocytes in vivo. I. The effect of IgG rabbit antibodies on rat erythrocytes. Transfusion (1967) 0.85
Cryptococcal meningitis with false-positive cytology in the CSF. Use of T-cell rosetting to exclude meningeal lymphoma. JAMA (1978) 0.84
Effect of HER2/neu expression on survival in non-small-cell lung cancer. Clin Lung Cancer (2001) 0.84
Serum anti-gamma-G globulin factors in paroxysmal nocturnal hemoglobinuria. Blood (1966) 0.84
Interleukin 1 secretion by human monocytes and macrophages. J Leukoc Biol (1984) 0.83
Treatment of polycythemia vera with hydroxyurea. Am J Hematol (1984) 0.83
Cell-cell interaction in erythropoiesis. Prog Hematol (1979) 0.83
Interleukin 1 secretion is not required for human macrophage support of T-cell proliferation. Cell Immunol (1984) 0.83
Heterogeneity of human lymphocyte Fc receptors. II. Relationship to antibody-dependent, cell-mediated cytotoxicity. Clin Exp Immunol (1978) 0.82
Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience. J Immunother (1991) (1991) 0.82
Phase I/II trial of human recombinant interferon gamma in renal cell carcinoma. J Biol Response Mod (1986) 0.82
Capping of peripheral blood lymphocyte C3 receptors in chronic lymphocytic leukemia: relationship to chemotherapy. Int J Cancer (1981) 0.81
The importance or red cell B12 and folate levels after partial gastrectomy. Am J Clin Nutr (1974) 0.81
Gene expression of insulin-like growth factors and receptors in neoplastic prostate tissues: correlation with clinico-pathological parameters. Cancer Invest (2001) 0.80
Lysozyme enhances monocyte-mediated tumoricidal activity: a potential amplifying mechanism of tumor killing. Blood (1981) 0.79
Microfilament and microtubule function in human monocytes. J Lab Clin Med (1977) 0.79
Open-label phase II trial of recombinant beta interferon (IFN-beta (ser)) in patients with colorectal cancer. Cancer Treat Rep (1987) 0.79
Effects of shortened erythropoietin exposure on sheep marrow cultures. Br J Haematol (1981) 0.79
Erythrocyte-bound C5 and C6 in autoimmune hemolytic anemia. J Immunol (1971) 0.79
Heterogeneity of human lymphocyte Fc receptors. I. Differential susceptibility to proteolysis. Clin Exp Immunol (1978) 0.78
Tumor necrosis factor infusions in humans prime neutrophils for hypochlorous acid production. Am J Physiol (1990) 0.78
Long-term management of polycythemia vera with hydroxyurea: a progress report. Semin Hematol (1986) 0.78
Fibrinogen St. Louis: a new inherited fibrinogen variant, coincidentally associated with hemophilia A. J Clin Invest (1972) 0.78
T-cell subset modulation of blood erythroid burst-forming unit proliferation. J Lab Clin Med (1983) 0.78
Modulation of adhesion molecules on human large granular lymphocytes by interleukin-2 in vivo and in vitro. Cell Immunol (1992) 0.78
Phase II trial of interferon-beta-serine in metastatic renal cell carcinoma. J Clin Oncol (1990) 0.78
Induction of nonspecific, proliferative dependent suppressor T lymphocytes in human mixed lymphocyte cultures. Cell Immunol (1980) 0.78
Lack of CNS penetration of docetaxel in a patient with leptomeningeal carcinomatosis. Ann Pharmacother (1998) 0.77
Lymphoblastic transformation of myelodysplastic syndrome. Am J Hematol (1986) 0.77
Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1. Exp Hematol (1992) 0.77
Central nervous system toxicity of biological response modifiers. Ann N Y Acad Sci (1990) 0.77
Severe thrombocytopenia in an acquired immunodeficiency syndrome patient associated with pentamidine-dependent antibodies specific for glycoprotein IIb/IIIa. Blood (1993) 0.77
Human peripheral blood erythroid burst forming unit (BFU(E)): evidence against T-lymphocyte requirement for proliferation in vitro. Exp Hematol (1980) 0.77
T-lymphocytes as a prognostic indicator in head and neck cancer. Arch Otolaryngol Head Neck Surg (1986) 0.76
Vinblastine fails to improve response of renal cancer to interferon alfa-n1: high response rate in patients with pulmonary metastases. J Clin Oncol (1991) 0.76
Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study. Cancer Treat Rep (1987) 0.76
Human monocyte to macrophage differentiation in vitro: characterization and mechanisms of the increased antibody-dependent cytotoxicity associated with differentiation. J Leukoc Biol (1984) 0.76
Biological and clinical effects of interferon-beta ser at two doses. J Interferon Res (1990) 0.76
Defective expression of T cell antigens in chronic lymphocytic leukaemia: relationship to T cell dysfunction. Br J Haematol (1984) 0.76
Spleen cell population changes and hemolytic anemia in F344 rats with large granular lymphocyte leukemia. Vet Pathol (1990) 0.75
Phase I/II trial of interferon-beta-serine in patients with renal cell carcinoma: immunological and biological effects. Cancer Res (1987) 0.75
A Southwest Oncology Group Phase I study of the sequential combination of recombinant interferon-gamma and recombinant interleukin-2 in patients with cancer. J Immunother (1991) (1992) 0.75
Role of cell--cell interaction in normal and abnormal erythropoiesis. Am J Pediatr Hematol Oncol (1980) 0.75
Effects of thiols on sheep erythrocytes resulting in enhanced rosette formation with human T lymphocytes. Proc Soc Exp Biol Med (1976) 0.75
Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group. Cancer (1996) 0.75
The ability of the latex-binding lymphocyte assay to predict in vivo efficacy of antilymphocyte sera. Transplantation (1972) 0.75
Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study. J Clin Oncol (1995) 0.75
Study of the malarial parasite-red cell relationship with the use of a new immunologic marker. J Lab Clin Med (1971) 0.75
Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia. Leukemia (1992) 0.75
Capping of mouse spleen lymphocyte C3 receptors: effects of pharmacologic agents. J Immunol (1980) 0.75
Lysozyme enhancement of tumor cell immunoprotection in a murine fibrosarcoma. Cancer Res (1981) 0.75
Aci-reductones enhance interleukin-2-induced lymphocyte cytotoxicity. Int J Immunopharmacol (1993) 0.75
Lack of significant changes in nutrition-related parameters with tumor necrosis factor treatment of cancer. Nutr Cancer (1993) 0.75
Pituitary component of the aromatic hydrocarbon-mediated expression of CYP2B and CYP2C11. Xenobiotica (1998) 0.75
Two mechanisms of erythrocyte destruction in penicillin-induced hemolytic anemia. N Engl J Med (1972) 0.75
The bacteria(B)--antibody(A)--complement(C) (BAC) rosette method for detecting C3 receptors (R): binding specificity and capping of human peripheral blood lymphocyte C3r. Cell Immunol (1980) 0.75